MARKET

NAMS

NAMS

NewAmsterdam Pharma Company N.V
NASDAQ
19.35
+0.32
+1.68%
After Hours: 19.35 0 0.00% 16:20 05/20 EDT
OPEN
19.03
PREV CLOSE
19.03
HIGH
19.58
LOW
18.47
VOLUME
503.89K
TURNOVER
--
52 WEEK HIGH
27.29
52 WEEK LOW
14.06
MARKET CAP
2.17B
P/E (TTM)
-10.4313
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at NAMS last week (0512-0516)?
Weekly Report · 1d ago
Wall Street Analysts Predict a 132.5% Upside in NewAmsterdam Pharma Company N.V. (NAMS): Here's What You Should Know
NASDAQ · 05/12 13:55
Weekly Report: what happened at NAMS last week (0505-0509)?
Weekly Report · 05/12 09:48
Analysts Offer Insights on Healthcare Companies: Iovance Biotherapeutics (IOVA), GH Research (GHRS) and NewAmsterdam Pharma Company (NAMS)
TipRanks · 05/09 12:50
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks · 05/09 12:42
Scotiabank Sticks to Their Buy Rating for NewAmsterdam Pharma Company (NAMS)
TipRanks · 05/09 12:40
RBC Capital Sticks to Their Buy Rating for NewAmsterdam Pharma Company (NAMS)
TipRanks · 05/09 11:19
NewAmsterdam Pharma Reports Q1 2025 Financial Results
TipRanks · 05/09 05:19
More
About NAMS
NewAmsterdam Pharma Company NV is a Netherlands based company. NewAmsterdam Pharma operates as a clinical-stage company and focuses on the research and development of transformative oral therapies for major cardiometabolic diseases. The Company is investigating obicetrapib, an oral, low-dose and once-daily, cholesteryl ester transfer protein (CETP) inhibitor, as the low-density lipoprotein cholesterol (LDL-C) lowering therapy to be used as an adjunct statin therapy for high-risk cardiovascular disease (CVD) patients. The Company is also testing obicetrapib as a fixed-dose combination therapy with ezetimibe in a secondary Phase 2 trial, ROSE2, for other diseases such as Alzheimer’s disease. The Company strives to offer its products around the world.

Webull offers NewAmsterdam Pharma Company NV stock information, including NASDAQ: NAMS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NAMS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NAMS stock methods without spending real money on the virtual paper trading platform.